Medication Use Among Pregnant Women With SARS-CoV-2 Infection and Risk of Hospitalization-A Study in Two Brazilian Hospitals

• Hoofdauteurs: Ricardo Rohweder (Auteur), Natálya G. Pereira (Auteur), Bruna H. Micheletti (Auteur), Jéssica Mosello (Auteur), Júlia R. M. Campos (Auteur), Matheus G. Pereira (Auteur), Cristina N. Santos (Auteur), Natália L. Simões (Auteur), Regina L. B. Matielo (Auteur), Lisandra S. Bernardes (Auteur), Maria L. R. Oppermann (Auteur), Maria C. O. Wender (Auteur), Angela Lupattelli (Auteur), Hedvig Nordeng (Auteur), Lavinia Schuler-Faccini (Auteur)
• Formaat: Boek
• Gepubliceerd in: Hindawi Limited, 2024-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

There is limited evidence about the use of medications among pregnant women with COVID-19, as well as risk factors for hospitalization due to COVID-19 in pregnancy. We aimed to describe the use of medications among SARS-CoV-2-positive pregnant women at the time around infection and identify predicto...